Evidence map›Paper›PMID 31029763›Full record

ArticleJournal of the American College of Surgeons2019

Plasma Transfusion Products and Contamination with Cellular and Associated Pro-Inflammatory Debris.

Yong B Tan, Richard R Rieske, Jon P Audia, Viktor M Pastukh, Gina C Capley, Mark N Gillespie, Alison A Smith, Danielle M Tatum, Juan C Duchesne, Matt E Kutcher and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Surgeons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Yong B TanDepartment of Surgery, University of South Alabama, Mobile, AL.
Richard R RieskeDepartment of Surgery, University of South Alabama, Mobile, AL.
Jon P AudiaDepartment of Microbiology and Immunology, University of South Alabama, Mobile, AL.
Viktor M PastukhDepartment of Cellular and Molecular Pharmacology, University of South Alabama, Mobile, AL.
Gina C CapleyDepartment of Cellular and Molecular Pharmacology, University of South Alabama, Mobile, AL.
Mark N GillespieDepartment of Cellular and Molecular Pharmacology, University of South Alabama, Mobile, AL.
Alison A SmithDepartment of Surgery, Tulane University, New Orleans, LA.
Danielle M TatumDepartment of Surgery, Tulane University, New Orleans, LA.
Juan C DuchesneDepartment of Surgery, Tulane University, New Orleans, LA.
Matt E KutcherDepartment of Surgery, University of Mississippi, Jackson, MS.
Jeffrey D KerbyDepartment of Surgery, University of Alabama-Birmingham, Birmingham, AL.
Jon D SimmonsDepartment of Surgery, University of South Alabama, Mobile, AL; Department of Cellular and Molecular Pharmacology, University of South Alabama, Mobile, AL; Department of Surgery, University of Alabama-Birmingham, Birmingham, AL. Electronic address: jdsimmons@health.southalabama.edu.
University of South Alabama · USTulane University · USUniversity of Alabama at Birmingham · USUniversity of Mississippi · US

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI MASON, SARAH · 2016 to 2025
$38.2M
UAB Center for Clinical and Translational Science (CCTS)UL1TR001417 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2015 to 2018
$31.4M
mtDNA DAMPS: a pharmacologic target in multi-organ system failureK08GM109113 · NIGMS · UNIVERSITY OF SOUTH ALABAMA · PI SIMMONS, JON DAVID · 2016 to 2019
$756k
NCATS NIH HHS UL1 TR001417NIGMS NIH HHS K08 GM109113NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

backgroundStored plasma products are widely regarded as being functionally acellular, obviating the need for leukoreduction. We tested the hypothesis that donor plasma is contaminated by leukocytes and platelets, which, after frozen storage, would release cellular debris in quantities sufficient to elicit significant pro-inflammatory responses. STUDY

designSamples of never-frozen liquid plasma from 2 regional Level I trauma centers were analyzed for leukocyte and platelet contamination. To determine if the cellular contamination and associated debris found in liquid plasma were at levels sufficient to evoke an innate immune response, known quantities of leukocytes were subjected to a freeze-thaw cycle, added to whole blood, and the magnitude of the inflammatory response was determined by induction of interleukin-6.

resultsUnits of never-frozen plasma from 2 regional Level I trauma centers located in Alabama and Louisiana contained significant amounts of leukocyte contamination (Louisiana, n = 22; 17.3 ± 4.5 million vs Alabama, n = 22; 11.3 ± 2.2 million) and platelet contamination (Louisiana, n = 21; 0.86 ± 0.20 billion vs Alabama, n = 22; 1.0 ± 0.3 billion). Cellular debris from as few as 1 million leukocytes induced significant increases in interleukin-6 levels (R

conclusionsStored plasma units from trauma center blood banks were highly contaminated with leukocytes and platelets, at levels more than 15-fold higher than sufficient to elicit ex vivo inflammatory responses. In light of paradigm shifts toward the use of more empiric plasma for treatment of hypovolemia, this study suggests that new manufacturing and quality-control processes are needed to eliminate previously unrecognized cellular contamination present in stored plasma products.

Indexed as

AlabamaBlood Component TransfusionBlood PlateletsBlood PreservationHumansLeukocytesLouisianaPlasmaQuality ControlTrauma Centers

Identifiers

PMID31029763
PMCPMC7682807
OpenAlexW2941881449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.